OVA1™  
  
OVA_postcard
  • OVA1™ is the first and only blood test cleared to help a physician evaluate the likelihood that a woman's ovarian mass is malignant or benign in conjunction with the physician's evaluation prior to a planned surgery
  • Developed by Vermillion, Inc., OVA1™ is now available nationally to women and their physicians through Quest Diagnostics.
UPCOMING SHOWS
  • August 6-7, 2010
    Florida Obstetric & Gynecology Section
    2010 Annual Meeting
    "Pathways to Excellence"
    Miami, Florida
  • August 26-29, 2010
    The Georgia Obstetrical & Gynecological Society
    2010 Annual Education Meeting
    Sea Island, Georgia
  • August 28, 2010
    National Ovarian Cancer Coalition
    3rd Annual NOCC Balance 5K
    Austin, Texas
 Copyright 2010 Vermillion